Calprotectin is a protein biomarker that indicates the migration of neutrophils to the intestinal mucosa, occuring during inflammatory bowel disease (IBD). It is used to distinguish between IBD and non-inflammatory disorders and to monitor IBD disease activity. It helps improve patient care and reduce health care costs by screening out patients with Irritable Bowel Syndrome (IBS), thus preventing the need for unnecessary endoscopy procedures.
Read MoreWhether you want to perform the test within Primary Care, in the Gastroenterology Clinic or the Hospital Laboratory, or even empower your patients to test themselves, Alpha Laboratories offers the widest range of test formats for the measurement of Human Faecal Calprotectin in the UK.
From individual home kits up to high throughput automated analysis we can support your calprotectin testing needs.
The NHS Centre for Evidence-based Purchasing concluded in 2010 that using calprotectin tests for differentiating between IBS and Inflammatory Bowel Disease (IBD) supports improvements in patient management and offers substantial cost savings.
Since 2013 NICE has recommended calprotectin tests to support clinicians with the differential diagnosis of IBD or irritable IBS in adults with recent onset lower gastrointestinal symptoms.
An interview with Prof. Dr. Patrick van Rheenen University Medical Center
Alison Jones, Consultant Clinical Biochemist, York and Scarborough NHS Foundation Trust
Collecting a faecal sample at home can seem a daunting process.
Dr Peter Rimmer, The Queen Elizabeth Hospital, Birmingham We are all
BÜHLMANN fCAL® Calprotectin ELISA
Quantum Blue® fCAL Rapid Test
Calprotectin Extraction
Patient Self-Testing
Calprotectin Sample Handling
The Workflow Revolution Continues for Serum Calprotectin June 29, 2023
New Presentation Format for UK NEQAS April 8, 2022
Point-of-Care Calprotectin Testing Just Got Easier with New and Improved Quantum Blue® III March 17, 2021
New App Helps Bowel Disease Patients Monitor Their Own Treatment February 24, 2021
